文献速递其他结缔组织病

外泌体在系统性硬化症中促进纤维化病变从受累细胞向正常细胞扩展的可能作用

Probable role of exosomes in the extension of fibrotic alterations from affected to normal cells in systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

系统性硬化症(SSc)是一种病因不明的系统性自身免疫病,以进行性皮肤和内脏纤维化导致严重残疾、器官衰竭和高死亡率为特征。其显著特征是纤维化改变可扩展至未受累组织,但机制不明。本文提出假说:SSc受累细胞释放的外泌体微囊泡可诱导正常或未受累细胞产生活化的促纤维化表型,从而介导纤维化扩展;外泌体通过细胞间通讯转移大分子内容物,改变受体细胞的分子通路和基因表达。

要点

  • SSc纤维化可扩展至未受累组织,机制尚未阐明。
  • 假说认为SSc受累细胞释放的外泌体诱导正常细胞促纤维化表型。
  • 外泌体转移大分子内容物改变受体细胞分子通路和基因表达。

核心结论

  • SSc纤维化从受累细胞向未受累细胞扩展的过程可能由SSc受累细胞释放的外泌体介导,外泌体诱导正常或未受累细胞产生活化的促纤维化表型。

研究设计与样本

  • 本文为假说性文章,基于对SSc纤维化扩展机制和外泌体生物学功能的文献分析提出假说,原文未报告系统检索范围。

主要发现

  • SSc的显著特征是纤维化改变扩展至未受累组织,但介导此过程的机制尚未阐明。
  • 外泌体是参与细胞间通讯系统的分泌性微囊泡,可将大分子内容物转移至远处靶细胞并诱导旁分泌效应,改变受体细胞的分子通路和基因表达。
  • 作者提出SSc受累细胞释放的外泌体可诱导正常或未受累细胞产生活化的促纤维化表型。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SSc is a systemic autoimmune disease of unknown etiology characterized by frequently progressive cutaneous and internal organ fibrosis causing severe disability, organ failure and high mortality. A remarkable feature of SSc is the extension of the fibrotic alterations to nonaffected tissues. The mechanisms involved in the extension of fibrosis have remained elusive. We propose that this process is mediated by exosome microvesicles released from SSc-affected cells that induce an activated profibrotic phenotype in normal or nonaffected cells. Exosomes are secreted microvesicles involved in an intercellular communication system. Exosomes can transfer their macromolecular content to distant target cells and induce paracrine effects in the recipient cells, changing their molecular pathways and gene expression. Confirmation of this hypothesis may identify the molecular mechanisms responsible for extension of the SSc fibrotic process from affected cells to nonaffected cells and may allow the development of novel therapeutic approaches for the disease.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Jimenez SA, Piera-Velazquez S. Probable role of exosomes in the extension of fibrotic alterations from affected to normal cells in systemic sclerosis. Rheumatology (Oxford). 2023. PMID: 35944210. doi:10.1093/rheumatology/keac451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。